Learning outcomes
By the end of this lesson you should be able to: define selective toxicity and explain how the differences between bacterial and human cells make it possible; distinguish bactericidal from bacteriostatic action and say when a static agent will not do; describe spectrum and how it guides empiric and then targeted therapy; construct an empiric regimen for a common infection from the site, severity and likely pathogens, and de-escalate it on cultures; list the reasons for combining antibiotics; and describe antimicrobial stewardship and the mechanisms by which resistance arises and spreads.
Prerequisites
Lessons 1 to 6, plus the microbiology module of the medical microbiology course — Gram staining, the common pathogens and the principles of culture.
The big idea
Bacteria are prokaryotes and humans are eukaryotes, and the gaps between us are the drug targets. Bacteria build a peptidoglycan cell wall that we do not have, which is what penicillin attacks. Bacteria read their messenger RNA on a 70S ribosome built from 30S and 50S subunits, while we use an 80S ribosome, which is what macrolides, tetracyclines and aminoglycosides attack. Bacteria synthesise their own folate, while we take it from the diet, which is what trimethoprim and the sulfonamides attack. Later lessons are the catalogue of these targets; this one is the strategy that decides how the catalogue is used — the right drug, the right dose, the right route, the shortest effective duration.
Bactericidal versus bacteriostatic
| Action | Meaning | Examples | Where the distinction decides |
|---|---|---|---|
| Bactericidal | Kills the organism outright, so the effect survives after the concentration falls | Penicillins, cephalosporins, aminoglycosides, quinolones | Endocarditis (the valve has no immune access), meningitis, neutropenic sepsis, and infective endocarditis — where the host immune system cannot finish the job |
| Bacteriostatic | Halts multiplication, relying on the host's immune system to clear the arrested organisms | Macrolides, tetracyclines, chloramphenicol, clindamycin, linezolid | Adequate for most soft-tissue infections in a patient with intact immunity, insufficient where immune clearance is impaired |
NoteThe bactericidal need is not absolute pharmacology but a compromise with immunity: antibiotics alone cannot sterilise a vegetation, a purulent collection or a prosthetic device, because immune cells and antibodies penetrate poorly and the drug kills only growing organisms. That is why the endocarditis regimen is combination and prolonged, and why an abscess is drained before the antibiotic works.
Spectrum and the empiric decision
Spectrum is the range of organisms a drug covers, and it cuts both ways: a broad-spectrum agent covers the likely pathogen before identification but also the gut flora, selecting resistance and causing clostridioides difficile infection. Empiric therapy is prescribed before the organism is known, guided by the site, the patient and the local antibiogram — the hospital's map of which organisms respond to which drugs, which varies ward to ward and country to country. Definite or targeted therapy follows cultures and sensitivities, narrowing the cover. The formal narrowing step is called de-escalation and is a stewardship obligation, not a review suggestion.
| Presentation | Common empiric regimen (a local example) | Rationale |
|---|---|---|
| Community-acquired pneumonia | Amoxicillin (or doxycycline); a beta-lactam with a macrolide if severe | Covers Streptococcus pneumoniae and atypicals such as Mycoplasma and Legionella |
| Cellulitis | Flucloxacillin; clindamycin in penicillin allergy | Covers streptococci and staphylococci, the skin organisms |
| Urinary tract infection | Nitrofurantoin or trimethoprim by local sensitivity | Concentrated in urine; nitrofurantoin spares the bowel flora |
| Meningitis | Ceftriaxone (plus amoxicillin and aciclovir if listerial or herpetic risk) | Must cover the likely organisms and cross the inflamed blood-brain barrier |
| Neutropenic sepsis | Piperacillin-tazobactam (an antipseudomonal beta-lactam) | The patient's own neutrophils are absent, so bactericidal cover for a wide range is mandatory |
Watch outCultures before antibiotics is the rule, but not when the rule kills. In septic shock antibiotics are given within the hour, cultures or not, because each hour of delay raises mortality; the cultures are then drawn as soon as they can be obtained without the delay. The protocol is the same in meningitis.
Choosing by site, dose and host
Four questions decide the prescription. Which organisms, given the site — the ones listed in the table above. Whether the drug gets there: the inflamed meninges admit ceftriaxone, metronidazole and rifampicin, but an aminoglycoside does not cross the blood-brain barrier and the abscess cavity has no vasculature. What dose — bactericidal effect can be time-dependent (beta-lactams, where the time above the minimum concentration is what kills) or concentration-dependent (aminoglycosides and quinolones, where the peak-to-minimum ratio is what kills, allowing once-daily dosing); and the duration — the shortest course that eradicates, since every extra day buys resistance and adverse effects without buying cure.
| Host factor | How it changes the choice | Example |
|---|---|---|
| Renal impairment | Renally cleared drugs accumulate and need dose or interval adjustment | Gentamicin and vancomycin levels are monitored; a quinolone dose drops in chronic kidney disease |
| Hepatic impairment | Metabolised drugs accumulate; narrow-index agents widen | Isoniazid and rifampicin hepatotoxicity is additive rather than just additive |
| Pregnancy and lactation | Avoid drugs that cross the placenta or enter milk | Tetracyclines stain fetal teeth; trimethoprim is a folate antagonist in the first trimester |
| Allergy | The prescription changes class, not brand | Penicillin anaphylaxis precludes penicillins but permits aztreonam or a non-beta-lactam |
| Age | The extremes of age alter clearance and flora | The neonate's immature liver cannot clear chloramphenicol, causing the grey baby syndrome |
Why and when to combine
| Reason | Mechanism of benefit | Example |
|---|---|---|
| Synergy | The two drugs together kill far more than either alone | A penicillin plus gentamicin in enterococcal endocarditis; the penicillin opens the wall for the aminoglycoside |
| Preventing resistance | A single mutation cannot defeat two mechanisms | Tuberculous therapy with four drugs; combination antiretroviral therapy |
| Empiric breadth | A single agent cannot cover all likely organisms | Piperacillin-tazobactam in neutropenic sepsis |
| Toxicity reduction | Two smaller doses match one large dose | Rifampicin, isoniazid, pyrazinamide and ethambutol for tuberculosis, each at a tolerable dose |
Prophylaxis
Prophylaxis is prescribed only where the risk of infection, or its consequence, justifies it: surgical prophylaxis is a single perioperative dose (cefazolin plus metronidazole for bowel or gynaecological work) timed to the incision, continued past twenty-four hours only for an ongoing risk; endocarditis prophylaxis is now reserved for the highest-risk cardiac states (prosthetic valve, previous endocarditis, certain congenital lesions) undergoing the procedures that cause bacteraemia — the gums; rheumatic fever prophylaxis follows a streptococcal episode for years; and contacts of meningococcal disease or invasively meningococcal contacts receive a clearing course of ciprofloxacin or rifampicin. Ordinary toothbrushing causes as much bacteraemia as a dental extraction, which is the reason prophylaxis is selective rather than routine.
Resistance and stewardship
Bacteria acquire resistance by mutation and plasmid exchange, and the principal mechanisms are enzymatic inactivation of the drug (the beta-lactamases, extended-spectrum and carba), alteration of the target so the drug no longer binds (methicillin-resistant staphylococcus, with its altered penicillin-binding protein), reduced uptake through a lost porin or thickened wall, and efflux pumps that expel it. Each unnecessary prescription selects these organisms in the flora and in the ward, and each partially treated infection lets them emerge — which is why stewardship is a prescribing duty: right drug, dose, route and duration; de-escalation on cultures; shortest effective course; avoidance of broad-spectrum agents where narrow will do; source control by drainage; and converting intravenous to oral therapy once the patient takes oral medicines and is improving. The resistance that crosses hospital boundaries is the direct arithmetic of those decisions.
Common mistakes
Watch outUsing a bacteriostatic drug to treat bacterial meningitis or infective endocarditis. The drug arrests the organism but cannot sterilise the site, where the immune system cannot reach, and the infection relapses when the antibiotic stops. These two conditions demand bactericidal therapy.
Watch outContinuing surgical prophylaxis until the drain comes out. Beyond a single perioperative dose, prophylaxis stops preventing surgical site infection — it switches to selecting resistant flora and clostridioides difficile.
Watch outSwitching to a fluoroquinolone for simple cystitis. Quinolones reserve (clostridioides difficile, tendon rupture, aneurysm and QT risks, widespread collateral damage) mean nitrofurantoin or trimethoprim by local sensitivity is preferred.
Watch outWaiting days for cultures in septic shock while the patient deteriorates. The delay of cultures must not delay antibiotics — blood cultures are taken as part of the same resuscitation, and the first dose goes in within the hour.
Check your understanding
What makes selective toxicity possible in antibacterial chemotherapy, and which three targets exploit it?
Why is a bacteriostatic agent insufficient in infective endocarditis?
How do time-dependent and concentration-dependent killing change the dosing of two common classes?
Multiple choice
Which statement about bactericidal drugs is correct?
Which mechanism explains aminoglycoside selectivity?
Which regimen choice best demonstrates empiric therapy guided by the local antibiogram?
Which combination is synergistic for enterococcal endocarditis?
Which action is NOT part of antimicrobial stewardship?